The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of blood eosinophil level with the clinical benefit of sorafenib in metastatic renal cell carcinoma.
Hailiang Zhang
No relevant relationships to disclose
Yao Zhu
No relevant relationships to disclose
Xiaojian Qin
No relevant relationships to disclose
Chunguang Ma
No relevant relationships to disclose
Hongkai Wang
No relevant relationships to disclose
Bo Dai
No relevant relationships to disclose
Guohai Shi
No relevant relationships to disclose
Dingwei Ye
No relevant relationships to disclose